Recently, the first drug-coated vascular coated stent for central venous lesions in China, a national prospective, multicenter, randomized controlled clinical trial with the Department of Vascular Surgery of West China Hospital of Sichuan University as the co-leader, was completed by the team of Prof. Zhao Jichun of the Department of Vascular Surgery and Prof. Cui Tianlei of the Department of Nephrology of West China Hospital of Sichuan University. The first case enrolled in our center marked the clinical trial project entered the full implementation stage. ​

Extracranial carotid artery stenosis is a major cause of atherosclerotic stroke. Transfemoral carotid artery stenting (TF-CAS) is an important therapeutic procedure for carotid artery stenosis. The balloon dilatation strategies during its treatment are preexpansion only (PRE), postexpansion only (POST), and preexpansion + postexpansion (PRE + POST). Concerns have been raised about higher neurological risk and hemodynamic instability associated with POST and PRE + POST during TF-CAS. Studies have shown that post dilatation for TF-CAS increases the risk of stroke by 2.4-fold and increases the risk of hemodynamic instability by 3.8-fold, which can lead to increased myocardial infarction (MI), LOS, and mortality. Transcarotid artery revascularization (TCAR) bypasses the manipulation of the device through the aortic arch and across the diseased segment, providing better embolic protection. Whether performing balloon dilatation during TCAR also results in the above adverse events is not yet known.At the recent 50th International Congress on Vascular and Endoluminal Vascularization (VEITH 2023), Professor Vikram S. Kashyap from the Cleveland Medical Center analyzed the results of performing PRE or POST or PRE+POST balloon dilation strategies during TCAR.

Adventitial Cystic Disease (ACD) is a rare disease.In 1947, Atkins et al. first described a case of adventitial cyst involving the right external iliac artery. To date, there have been about 600 reports covering about 800 patients, with over 80% of lesions involving the popliteal artery. At the recent 50th International Vascular and Endoluminal Vascular Congress (VEITH 2023), Prof. Irwin V Mohan from the University of Sydney, Australia, shared the management of popliteal artery epiphyseal cyst disease.

Isolated common iliac artery aneurysms (CIAA) Due to their rarity and uncertainty of progression, there is no consensus in the field of vascular surgery as to when and how to treat these lesions. Traditional treatment strategies are usually based on the size and growth rate of the aneurysm, as well as the risk of rupture. However, recent studies have provided new insights, suggesting that isolated CIAAs are extremely unlikely to rupture at smaller sizes.